Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: A U.S.–Canadian multicenter study

British HIV Association guidelines for the management of coinfection with HIV‐1 and hepatitis B or C virus 2010

“…The rate of hepatitis B clearance is also lower, with up to 20-40% of infected patients progressing to chronic (46 months) infection [82,83]. Progression to liver cancer is more rapid, with HIV-positive patients with HBV infection developing liver cancer younger than patients with HBV infection alone [52,[82][83][84].…”

Sorafenib Therapy for Hepatocellular Carcinoma in an HIV–HCV Coinfected Patient: A Case Report

“…The reduction in AIDS-defining malignancies such as Kaposi's sarcoma and non-Hodgkin's lymphomas has been accompanied by an increase in non-AIDS-defining malignancies [6], and HCC secondary to viral hepatitis has emerged as a major source of morbidity and mortality in HIV-infected people [7][8][9][10][11]. The prevalence of chronic HCV in HIV-infected patients is about 33%, but this varies geographically and, because of the shared mode of transmission, is much higher in certain populations, such as injection drug users and hemophiliacs.…”

Neoplasias en pacientes con infección por VIH: Estudio descriptivo de 129 casos en el período 1993-2010

“…La mejor manera de prevenir la aparición de hepatocarcinoma es el tratamiento de las hepatitis víricas, así como la implantación de programas de cribado. La mortalidad inherente a este tipo de cáncer todavía es muy elevada, en nuestra serie fallecen cinco de nueve pacientes durante el seguimiento, resultados similares a los de otras series [43][44] .…”